Figure 5.

Survival of patients with and without overexpression of c-erbB2 and topoisomerase IIα. The difference between patients without overexpression of c-erbB2 or topoisomerase (broken line), patients with tumors overexpressing one of the two proteins (c-erbB2, dot–dashed line; topoisomerase IIα, solid line), and patients with tumors overexpressing both c-erbB2 and topoisomerase IIα (dotted line) was significant (log rank 29.71; P < 0.0001).

Fritz et al. Breast Cancer Research 2005 7:R374-R384   doi:10.1186/bcr1012
Download authors' original image